Wird geladen...
The Role of Glucagon in the Acute Therapeutic Effects of SGLT2 Inhibition
Sodium–glucose cotransporter 2 inhibitors (SGLT2i) effectively lower plasma glucose (PG) concentration in patients with type 2 diabetes, but studies have suggested that circulating glucagon concentrations and endogenous glucose production (EGP) are increased by SGLT2i, possibly compromising their gl...
Gespeichert in:
| Veröffentlicht in: | Diabetes |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Diabetes Association
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7679772/ https://ncbi.nlm.nih.gov/pubmed/33004472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db20-0369 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|